A minimalist, high-fidelity recovery tracker that successfully adds cardiac screening while currently grappling with FDA warnings over its blood pressure estimations.

WHOOP 5.0 Review: A Performance-Focused Wearable Navigating Clinical Expansion

Published Mar 24, 2026
|
Reviewed by Dr. James Miller, MD, MD
|
Testing 30 days
|
Evidence Moderate Clinical Evidence
PEER REVIEWED

The WHOOP 5.0 (specifically the 'MG' or medical-grade iteration) represents the company's most ambitious attempt to move beyond fitness and into clinical health monitoring. The device retains its signature screenless, low-profile design, focusing on 'Strain' and 'Recovery' metrics derived from high-resolution heart rate variability (HRV) and sleep data. A major hardware update includes the 'Heart Screener' feature, which provides on-demand single-lead ECG recordings and background notifications for irregular heart rhythms suggestive of Atrial Fibrillation (AFib). These features are classified as medically regulated and are intended to provide clinical-grade cardiac insights. However, the device's rollout of 'Blood Pressure Insights' (BPI) has been controversial; a 2025 FDA Warning Letter identified BPI as an unapproved medical device, noting that its daily systolic and diastolic estimations are inherently associated with the diagnosis of hypertension and thus require formal clearance. For sleep, WHOOP 5.0 remains a top-tier performer, tracking duration, stages, and efficiency, and introducing a 'Sleep Stress' metric to quantify physiological disturbances. While the device is an excellent wellness tool, users should be cautious regarding its un-cleared blood pressure claims until formal FDA authorization is obtained.

Worth Considering Moderate Clinical Evidence FDA Review Pending
WHOOP 5.0 - Medical Device

WHOOP 5.0

WHOOP

$239.00
84 /100

Our Score

Clinical Performance Metrics

Quantitative assessment based on clinical testing protocols

Diagnostic Accuracy

Strong for heart rate and sleep staging, but currently lacks clearance for its blood pressure estimation feature, which the FDA has flagged as adulterated and misbranded.

78/100

Ease of Use

Completely passive data collection with no screen to manage; the battery pack allows charging without removing the device.

92/100

Wearing Comfort

One of the most comfortable wearables on the market; flexible bands and multiple placement options (wrist, arm, or apparel) make it ideal for 24/7 use.

95/100

Value for Money

The mandatory monthly subscription model can be more expensive over time compared to competitors with one-time purchase options like the Oura Ring or Apple Watch.

70/100

Quick Take

Key findings from our clinical evaluation

+
Strengths

  • Medically regulated Heart Screener feature for on-demand ECG and AFib notifications.
  • Industry-leading wearable comfort and versatile placement options.
  • Advanced sleep metrics including Sleep Stress and sleep consistency tracking.
  • Unique charging system allows the device to remain on the body 24/7.
  • Deeply integrated mobile app provides actionable daily recovery insights.

Limitations

  • Blood Pressure Insights feature received a 2025 FDA Warning Letter for lack of clearance.
  • Requires a continuous monthly subscription to access any data.
  • No on-device screen for real-time time or metric checks.

Real-World Usage

Practical considerations for daily operation

Daily Routine Impact

Fits seamlessly into a 24/7 lifestyle without needing removal for charging; focuses the user on recovery and strain balance through a high-quality app experience.

Learning Curve

Master in a day

Maintenance

Periodic cleaning of the sensor and washing of the fabric strap; regular charging of the slide-on battery pack.

Portability

Highly portable; allows charging while wearing, making it ideal for long-duration travel.

Manual Use

The device has no screen or buttons; all interaction must be done via the companion mobile application.

Cost & Coverage Analysis

Financial considerations and HSA / FSA eligibility

Pricing Breakdown

Device Price $239.00
WHOOP Membership (Access to App, analytics, and coaching; Hardware included with membership.)
Free
HSA / FSA Eligibility Not Typically Eligible

HSA/FSA Guidance

Subscription fees are rarely covered by insurance, though some employers may provide wellness reimbursements.

Cost Comparison

Zero upfront cost with membership, but higher long-term cost of ownership due to mandatory subscription fees.

Patient Suitability

Clinical indications and contraindications

Indicated For

  • Athletes and high-performance individuals focused on strain and recovery.
  • Users who prefer a minimalist, screen-free wearable.
  • Individuals wanting 24/7 continuous health data without removal for charging.

Contraindications

  • Users seeking an FDA-cleared home blood pressure monitor.
  • Individuals who want a wearable with a built-in watch face or screen.

Age Considerations

Medically regulated features like the Heart Screener are generally intended for users 22 years of age and older.

Clinical Efficacy Assessment

Evidence-based evaluation of clinical performance

Sleep Stage Identification

Assesses the accuracy of identifying REM, Light, and Deep sleep states.

High correlation with clinical sleep staging using movement and heart rate variability data.

Respiratory Event Detection

Evaluates accuracy in detecting individual breathing disturbances.

Tracks respiratory rate and 'Sleep Stress,' which correlates with physiological disturbances but is not a clinical respiratory event detector.

In-Lab PSG Correlation

Measures how the device results correlate with in-lab polysomnography.

While generally reliable for wellness, the absence of FDA clearance for its blood pressure feature limits its use as a clinical diagnostic accessory.

Comparative Performance

Ranked #22 of 25 clinically evaluated home sleep tests devices

1
Withings Sleep Analyzer

Withings Sleep Analyzer

Withings

Top Rated
2
Sunrise Home Sleep Test

Sunrise Home Sleep Test

Sunrise SA

3
NightOwl Home Sleep Apnea Test

NightOwl Home Sleep Apnea Test

ResMed

22
WHOOP 5.0

WHOOP 5.0

WHOOP

You're viewing this
84 /100

Clinical Context

Our #1-ranked home sleep tests device demonstrated superior performance across key clinical metrics. Compare detailed specifications to make an evidence-based selection.

Clinical Recommendation

Final assessment and prescribing guidance

WHOOP 5.0 remains a premier choice for performance tracking, but its recent regulatory hurdles regarding blood pressure insights mean users should primarily rely on it for sleep and cardiac screening rather than metabolic or arterial monitoring.

Recommend If

You want the most comfortable performance wearable on the market with added medically-regulated AFib notifications.

Avoid If

You require a confirmed FDA-cleared blood pressure device or dislike monthly subscription models.

Clinical Summary

84 /100

Composite Score

Worth Considering

Recommendation

$239

Price Point

Evidence: Moderate
Tested: 30 days

Where to Buy

Verified purchase options and current availability

WHOOP Official Store

Price: $239.00
1-3 business days

Device included with subscription[cite: 553, 1109]; membership required for operation.

Shop Now

Amazon

Price: $239.00
Next day Prime delivery

Standard membership starter kit.

Shop Now

Important Information

  • • Prices and availability subject to change
  • • Some devices may require a prescription
  • • HSA / FSA eligibility: Not Typically Eligible
  • • Purchase from authorized retailers for warranty protection
Visit Manufacturer Website

Alternative Devices

Superior comfort and recovery analytics compared to the Oura Ring or Amazfit Helio, but currently lagging in regulatory clearance for its newest medical claims.

Testing Methodology

Evaluation of cardiac monitoring consistency during high-strain activity and rest, combined with a detailed review of the FDA's 2025 regulatory findings regarding the device's blood pressure estimation algorithms.

Medical Review: Medical professionals value WHOOP for its high-resolution HRV data, which is among the most consistent in the consumer market. However, the 2025 FDA Warning Letter regarding Blood Pressure Insights serves as a reminder that estimations of systolic/diastolic pressure from wearables are not yet a substitute for traditional cuff-based measurements.

Medical Disclaimer

This review is for informational purposes only and does not constitute medical advice. Individual results may vary. Always consult with healthcare professionals before making medical device decisions. Clinical recommendations should be individualized based on patient-specific factors.